SARS-CoV-2 viral clearance and viral load kinetics in young children (1–6 years) compared to adults: Results of a longitudinal study in Germany

Objective To investigate SARS-COV-2 viral clearance and viral load kinetics in the course of infection in children aged 1–6 years in comparison with adults. Methods Prospective cohort study of infected daycare children and staff and their close contacts in households from 11/2020 to 06/2021. Adult participants took upper respiratory tract specimen from themselves and/or their children, for PCR tests on SARS-CoV-2. Data on symptoms and exposure were used to determine the date of probable infection for each participant. We determined (a) viral clearance, and (b) viral load dynamics over time. Samples were taken from day 4–6 to day 16–18 after diagnosis of the index case in the respective daycare group (5 samples per participant). Results We included 40 children (1–6 years) and 67 adults (18–77 years) with SARS-CoV-2 infection. Samples were available at a mean of 4.3 points of time per participant. Among the participants, the 12-day study period fell in different periods within the individual course of infection, ranging from day 5–17 to day 15–26 after assumed infection. Children reached viral clearance at a median of 20 days after assumed infection (95% CI 17–21 days, Kaplan-Meier Analysis), adults at 23 days (95% CI 20–25 days, difference not significant). In both children and adults, viral load decreased over time with trajectories of the mean viral load not being statistically different between groups. Kaplan-Meier calculations show that from day 15 (95% CI 13–15), 50% of all participants had a viral load <1 million copies/ml, i.e. were no longer infectious or negative. Conclusion Children aged 1–6 and adults infected with SARS-CoV-2 (wild type and Alpha variant) did not differ significantly in terms of viral load kinetics and time needed to clear the virus. Therefore, containment measures are important also in the daycare settings as long as the pandemic continues.

[1]  U. Buchholz,et al.  Transmission of SARS-CoV-2 among children and staff in German daycare centres , 2022, Epidemiology and Infection.

[2]  A. Berger,et al.  RNA reference materials with defined viral RNA loads of SARS-CoV-2—A useful tool towards a better PCR assay harmonization , 2022, PloS one.

[3]  U. Buchholz,et al.  Transmission of SARS-CoV-2 among children and staff in German daycare centers: results from the COALA study , 2021, medRxiv.

[4]  U. Buchholz,et al.  SARS-CoV-2 Transmissibility Within Day Care Centers—Study Protocol of a Prospective Analysis of Outbreaks in Germany , 2021, Frontiers in Public Health.

[5]  M. R. Moreira,et al.  Social isolation and its impact on child and adolescent development: a systematic review , 2021, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.

[6]  A. Baiker,et al.  Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany , 2021, Epidemiology and Infection.

[7]  M. Rieder,et al.  Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting. , 2021, JAMA pediatrics.

[8]  A. Nitsche,et al.  Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 , 2021, Virology journal.

[9]  G. Biele,et al.  Estimating infectiousness throughout SARS-CoV-2 infection course , 2021, Science.

[10]  E. Albert,et al.  Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults , 2021, Clinical Microbiology and Infection.

[11]  Zahra A. Premji,et al.  SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19 , 2021, medRxiv.

[12]  E. Crawford,et al.  Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults , 2021, Scientific Reports.

[13]  H. Hölling,et al.  Auswirkungen des COVID-19-Pandemiegeschehens und behördlicher Infektionsschutzmaßnahmen auf die psychische Gesundheit von Kindern und Jugendlichen , 2020 .

[14]  R. Gupta,et al.  Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India , 2020, Indian Pediatrics.

[15]  M. Cevik,et al.  SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis , 2020, The Lancet Microbe.

[16]  Bo Kyeung Jung,et al.  Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period , 2020, International Journal of Infectious Diseases.

[17]  Joseph M. Campos,et al.  Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, The Journal of Pediatrics.

[18]  R. DeBiasi,et al.  Kinetics of viral clearance and antibody production across age groups in SARS-CoV-2 infected children , 2020, The Journal of Pediatrics.

[19]  S. Yerly,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) , 2020, Clinical Infectious Diseases.

[20]  P. Giorgi Rossi,et al.  Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy , 2020, BMJ Open.

[21]  S. Dubey,et al.  Impact of COVID -19 on children: special focus on the psychosocial aspect. , 2020, Minerva pediatrica.

[22]  Lin Qi,et al.  Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study , 2020, International Journal of Infectious Diseases.

[23]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[24]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[25]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[26]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[27]  Alan S. Perelson,et al.  Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..

[28]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[29]  Mark H. Weir,et al.  Development of a Dose‐Response Model for SARS Coronavirus , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[30]  A. Woll,et al.  Zur Situation der körperlich-sportlichen Aktivität von Kindern und Jugendlichen während der COVID-19 Pandemie in Deutschland : Die Motorik-Modul Studie (MoMo) , 2021 .

[31]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .